/ZYBT

ZYBT Stock - Zhengye Biotechnology Holding Limited

Q: What is the analyst price target for ZYBT?

Analyst price target information is not currently available for ZYBT.

Q: What is ZYBT's market cap?

Market capitalization information is not currently available for ZYBT.

Healthcare|Drug Manufacturers - Specialty & Generic|NASDAQ

$1.85+2.21%

+$0.04 (+2.21%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $2.04

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for ZYBT

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.00

52W High$14.30

52W Low$1.40

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021
Revenue	$186.36M	$211.65M	$260.27M	$214.07M
Gross Profit	$91.30M	$129.85M	$153.52M	$125.39M
Gross Margin	49.0%	61.4%	59.0%	58.6%
Operating Income	$16.44M	$44.99M	$65.83M	$52.38M
Net Income	$11.31M	$31.46M	$46.73M	$38.96M
Net Margin	6.1%	14.9%	18.0%	18.2%
EPS	$0.00	$0.00	$0.00	$0.00

Company Overview

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Visit Website

Frequently Asked Questions about ZYBT

What is ZYBT's current stock price?

Zhengye Biotechnology Holding Limited (ZYBT) is currently trading at $1.85 per share. The stock has moved +2.21% today.

What is the analyst price target for ZYBT?

No analyst price targets are currently available for this stock.

What sector is Zhengye Biotechnology Holding Limited in?

Zhengye Biotechnology Holding Limited operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the NASDAQ exchange.

What is ZYBT's market cap?

Zhengye Biotechnology Holding Limited has a market capitalization of $0.09 billion, making it a small-cap company.

Does ZYBT pay dividends?

No, Zhengye Biotechnology Holding Limited does not currently pay a dividend to shareholders.